On December 12–13, i-SENS hosted the “2025 CareSens Air Symposium” in collaboration with the The Korean Association of Diabetes Nurse Educators (KADNE), bringing together key opinion leaders and diabetes education nurses from major medical institutions across South Korea.

The two-day symposium welcomed approximately 40 healthcare professionals, providing a platform to exchange insights on clinical CGM utilization and future strategies, centered on CareSens Air.

i-SENS’s Technological Competitiveness in the Global CGM Market

The symposium opened with discussions on global CGM market trends and the evolving role of CGM in diabetes care, alongside an overview of i-SENS’s CGM roadmap and technology strategy. Sessions highlighted the scientific foundation behind CareSens Air and reinforced i-SENS’s commitment to advancing CGM technology through continuous innovation and clinical validation.

Clinical Perspectives from Real-World Practice

Healthcare professionals shared real-world practices from clinical and educational settings, offering practical perspectives on how CGM is applied in daily diabetes management. Discussions emphasized the growing importance of data-driven education, moving beyond device operation toward supporting behavioral change using qualitative glucose metrics such as Time in Range (TIR). Practical guidance on CGMS troubleshooting and calibration was also shared, providing practical insights that can be readily applied in clinical practice.

Strengthening Collaboration with Healthcare Professionals

The symposium underscored the importance of close collaboration with diabetes education nurses, who play a significant role in patient education and long-term diabetes management. Participants expressed strong interest in CareSens Air, noting its accuracy and usability, and shared their intention to further integrate CGMS into clinical education programs.

This symposium reflects i-SENS’s ongoing commitment to working closely with healthcare professionals to enhance the clinical value of CGM and support the continued advancement of diabetes care.